{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:28:31Z","timestamp":1792625311216,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T00:00:00Z","timestamp":1723334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011022","name":"Vertex Pharmaceuticals Incorporated","doi-asserted-by":"publisher","award":["ISS-2020-109445"],"award-info":[{"award-number":["ISS-2020-109445"]}],"id":[{"id":"10.13039\/100011022","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jcf.2024.08.001","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T13:10:50Z","timestamp":1725628250000},"page":"984-990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["A longitudinal study assessing the impact of elexacaftor\/tezacaftor\/ivacaftor on gut transit and function in people with cystic fibrosis using magnetic resonance imaging (MRI)"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2666-2673","authenticated-orcid":false,"given":"Alexander","family":"Yule","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7243-3014","authenticated-orcid":false,"given":"Christabella","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arantxa","family":"Recto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6268-3219","authenticated-orcid":false,"given":"Florence","family":"Lockwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neele S","family":"Dellschaft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5483-1027","authenticated-orcid":false,"given":"Caroline L","family":"Hoad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Zagoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen G","family":"Mainz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7944-3709","authenticated-orcid":false,"given":"Giles","family":"Major","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen L","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4900-4817","authenticated-orcid":false,"given":"Penny A","family":"Gowland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9092-4300","authenticated-orcid":false,"given":"Luca","family":"Marciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6371-4500","authenticated-orcid":false,"given":"Robin C","family":"Spiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5494-5438","authenticated-orcid":false,"given":"Alan R","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2024.08.001_bib0001","first-page":"1","article-title":"Thinking outside the box: a review of gastrointestinal symptoms and complications in cystic fibrosis","author":"Yule","year":"2023","journal-title":"Expert Rev Respir Med"},{"issue":"18","key":"10.1016\/j.jcf.2024.08.001_bib0002","article-title":"A grumbling concern: a survey of gastrointestinal symptoms in cystic fibrosis in the modulator era [version 2; peer review: 2 approved, 3 approved with reservations]","volume":"3","author":"Calthorpe","year":"2024","journal-title":"NIHR Open Res"},{"issue":"1","key":"10.1016\/j.jcf.2024.08.001_bib0003","first-page":"09","article-title":"How can we relieve gastrointestinal symptoms in people with cystic fibrosis? An international qualitative survey","volume":"7","author":"Smith","year":"2020","journal-title":"BMJ Open Respir Res"},{"issue":"2","key":"10.1016\/j.jcf.2024.08.001_bib0004","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jcf.2022.10.006","article-title":"Multicenter prospective study showing a high gastrointestinal symptom burden in cystic fibrosis","volume":"22","author":"Moshiree","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"8","key":"10.1016\/j.jcf.2024.08.001_bib0005","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/thorax-2023-220100","article-title":"A refresh of the top 10 research priorities in cystic fibrosis","volume":"78","author":"Rowbotham","year":"2023","journal-title":"Thorax"},{"issue":"SUPPL 1","key":"10.1016\/j.jcf.2024.08.001_bib0006","first-page":"A98","article-title":"The james lind alliance and cystic fibrosis: a journey towards co-production of research","volume":"105","author":"Rowbotham","year":"2020","journal-title":"Arch. Dis. Child."},{"issue":"19","key":"10.1016\/j.jcf.2024.08.001_bib0007","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor\u2013Tezacaftor\u2013Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"New England Journal of Medicine"},{"issue":"18","key":"10.1016\/j.jcf.2024.08.001_bib0008","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jcf.2024.08.001_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.877118","article-title":"Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduces Abdominal Symptoms in Cystic Fibrosis-Early results Obtained With the CF-Specific CFAbd-Score","volume":"13","author":"Mainz","year":"2022","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.jcf.2024.08.001_bib0010","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jcf.2023.10.001","article-title":"Reduction in abdominal symptoms (CFAbd-Score), faecal M2-pyruvate-kinase and Calprotectin over one year of treatment with Elexacaftor-Tezacaftor-Ivacaftor in people with CF aged \u226512 years - The RECOVER study","volume":"23","author":"Mainz","year":"2024","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2024.08.001_bib0011","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jcf.2020.06.004","article-title":"Postprandial changes in gastrointestinal function and transit in cystic fibrosis assessed by Magnetic Resonance Imaging","volume":"20","author":"Ng","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"65","key":"10.1016\/j.jcf.2024.08.001_bib0012","article-title":"A randomised crossover trial of tezacaftor-ivacaftor for gut dysfunction in cystic fibrosis with magnetic resonance imaging (MRI) outcomes: a pilot study. [version 2; peer review: 2 approved, 1 approved with reservations]","volume":"3","author":"Ng","year":"2024","journal-title":"NIHR Open Res"},{"issue":"3","key":"10.1016\/j.jcf.2024.08.001_bib0013","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/apt.16673","article-title":"Small bowel water content assessed by MRI in health and disease: a collation of single-centre studies","volume":"55","author":"Dellschaft","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.jcf.2024.08.001_bib0014","first-page":"G38","article-title":"Differential transit of liquids and solid residue through the human ileum","volume":"245","author":"Kerlin","year":"1983","journal-title":"Am J Physiol"},{"issue":"3","key":"10.1016\/j.jcf.2024.08.001_bib0015","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/0016-5085(87)90024-2","article-title":"Emptying of the terminal ileum in intact humans. Influence of meal residue and ileal motility","volume":"92","author":"Spiller","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcf.2024.08.001_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2020.00018","article-title":"Manometry of the Human Ileum and Ileocaecal Junction in Health, Disease and Surgery: a Systematic Review","volume":"7","author":"Liu","year":"2020","journal-title":"Front Surg"},{"issue":"6","key":"10.1016\/j.jcf.2024.08.001_bib0017","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3\u201395-yr age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"European Respiratory Journal"},{"key":"10.1016\/j.jcf.2024.08.001_bib0018","unstructured":"Marsh R., Santos C.D., Yule A., et al. Impact of extended Elexacaftor\/Tezacaftor\/Ivacaftor therapy on the gut microbiome in cystic fibrosis. J Cyst Fibros."},{"issue":"9","key":"10.1016\/j.jcf.2024.08.001_bib0019","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1080\/003655299750025327","article-title":"Psychometric validation of a constipation symptom assessment questionnaire","volume":"34","author":"Frank","year":"1999","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"10.1016\/j.jcf.2024.08.001_bib0020","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s40271-019-00361-2","article-title":"Validity and Reliability of a Novel Multimodal Questionnaire for the Assessment of Abdominal Symptoms in People with Cystic Fibrosis (CFAbd-Score)","volume":"12","author":"Jaudszus","year":"2019","journal-title":"The Patient - Patient-Centered Outcomes Research"},{"key":"10.1016\/j.jcf.2024.08.001_bib0021","unstructured":"Anon. National Institutes of Health. About MIPAV Bethesda, MD2019 [Available from: https:\/\/mipav.cit.nih.gov\/."},{"issue":"3","key":"10.1016\/j.jcf.2024.08.001_bib0022","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1088\/0031-9155\/60\/3\/1367","article-title":"Measurement of gastric meal and secretion volumes using magnetic resonance imaging","volume":"60","author":"Hoad","year":"2015","journal-title":"Phys Med Biol"},{"issue":"9","key":"10.1016\/j.jcf.2024.08.001_bib0023","doi-asserted-by":"crossref","first-page":"e13883","DOI":"10.1111\/nmo.13883","article-title":"Motor dysfunction of the gut in cystic fibrosis","volume":"32","author":"Malagelada","year":"2020","journal-title":"Neurogastroenterol Motil"},{"issue":"1","key":"10.1016\/j.jcf.2024.08.001_bib0024","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/MPG.0b013e318290d112","article-title":"Delayed small bowel transit in children with cystic fibrosis and pancreatic insufficiency","volume":"57","author":"Rovner","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"8","key":"10.1016\/j.jcf.2024.08.001_bib0025","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s10620-012-2209-1","article-title":"Intestinal pH and Gastrointestinal Transit Profiles in Cystic Fibrosis Patients Measured by Wireless Motility Capsule","volume":"58","author":"Gelfond","year":"2013","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.jcf.2024.08.001_bib0026","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jcf.2021.12.007","article-title":"Magnetic resonance imaging of the gastrointestinal tract shows reduced small bowel motility and altered chyme in cystic fibrosis compared to controls","volume":"21","author":"Dellschaft","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.08.001_bib0027","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jcf.2017.07.014","article-title":"Bacterial overgrowth, dysbiosis, inflammation, and dysmotility in the Cystic Fibrosis intestine","volume":"16","author":"Jill","year":"2017","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.jcf.2024.08.001_bib0028","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/ajg.2016.538","article-title":"Distinct Abnormalities of Small Bowel and Regional Colonic Volumes in Subtypes of Irritable Bowel Syndrome Revealed by MRI","volume":"112","author":"Lam","year":"2017","journal-title":"Off J Am Coll Gastroenterol | ACG"},{"issue":"9","key":"10.1016\/j.jcf.2024.08.001_bib0029","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009753","article-title":"The cystic fibrosis intestine","volume":"3","author":"De Lisle","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jcf.2024.08.001_bib0030","unstructured":"Anon. GRAMPUS-CF. Gut Research Advancing a Mechanistic and Personalised Understanding of Symptoms in Cystic Fibrosis (GRAMPUS-CF) 2023 [Available from: https:\/\/www.grampus-cf.org\/."}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199324008270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199324008270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:13:12Z","timestamp":1788246792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199324008270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1569199324008270"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2024.08.001","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A longitudinal study assessing the impact of elexacaftor\/tezacaftor\/ivacaftor on gut transit and function in people with cystic fibrosis using magnetic resonance imaging (MRI)","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2024.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}